Pzena Investment Management LLC Reduces Holdings in HCA Healthcare, Inc. $HCA

Pzena Investment Management LLC lowered its stake in HCA Healthcare, Inc. (NYSE:HCA) by 6.5% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 94,261 shares of the company’s stock after selling 6,569 shares during the quarter. Pzena Investment Management LLC’s holdings in HCA Healthcare were worth $44,608,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the company. James Investment Research Inc. increased its position in shares of HCA Healthcare by 39.3% in the first quarter. James Investment Research Inc. now owns 4,444 shares of the company’s stock valued at $2,103,000 after acquiring an additional 1,254 shares during the period. Vertrix Wealth Management LLC purchased a new position in HCA Healthcare during the 1st quarter valued at about $269,000. USS Investment Management Ltd raised its position in HCA Healthcare by 1.8% during the 1st quarter. USS Investment Management Ltd now owns 29,052 shares of the company’s stock valued at $13,740,000 after purchasing an additional 521 shares during the last quarter. MQS Management LLC lifted its stake in HCA Healthcare by 48.3% in the first quarter. MQS Management LLC now owns 1,530 shares of the company’s stock worth $724,000 after acquiring an additional 498 shares during the period. Finally, Premier Path Wealth Partners LLC increased its position in HCA Healthcare by 17.8% during the 1st quarter. Premier Path Wealth Partners LLC now owns 2,302 shares of the company’s stock valued at $1,089,000 after purchasing an additional 348 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the stock. KeyCorp cut their target price on shares of HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating on the stock in a research note on Monday, April 27th. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of HCA Healthcare in a research report on Wednesday. Wall Street Zen lowered HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, May 2nd. Weiss Ratings cut HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, June 9th. Finally, JPMorgan Chase & Co. lowered their price objective on HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating for the company in a research report on Tuesday, May 19th. Fifteen analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $503.00.

HCA Healthcare Price Performance

HCA Healthcare stock opened at $393.33 on Thursday. HCA Healthcare, Inc. has a one year low of $330.00 and a one year high of $556.52. The business’s fifty day moving average is $403.12 and its 200 day moving average is $463.33. The stock has a market capitalization of $87.26 billion, a PE ratio of 13.53, a price-to-earnings-growth ratio of 1.24 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company had revenue of $19.11 billion for the quarter, compared to the consensus estimate of $19.09 billion. During the same quarter in the prior year, the company posted $6.45 EPS. HCA Healthcare’s revenue was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, sell-side analysts expect that HCA Healthcare, Inc. will post 30.07 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th were issued a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend was Tuesday, June 16th. HCA Healthcare’s dividend payout ratio is presently 10.73%.

HCA Healthcare Company Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.